Imatinib


ATC CODE

  • L01XE01

INDICATIONS AND NEMLC RECOMMENDATIONS

INDICATIONS AND NEMLC RECOMMENDATIONS 1

INDICATION

  • Chronic phase of chronic myeloid leukemia.

NEMLC RECOMMENDATION

  • Approved

REVIEW INDICATORS

  • None

DATE RATIFIED

  • 27 March 2014



INDICATIONS AND NEMLC RECOMMENDATIONS 2

INDICATION

  • Gastrointestinal Stromal Tumours (GIST) - adjuvant therapy

NEMLC RECOMMENDATION

  • Approved

REVIEW INDICATORS

  • None

DATE RATIFIED

  • 25 June 2015



INDICATIONS AND NEMLC RECOMMENDATIONS 3

INDICATION

  • Gastrointestinal Stromal Tumours (GIST) ) - metastatic therapy.

NEMLC RECOMMENDATION

  • Approved

REVIEW INDICATORS

  • None

DATE RATIFIED

  • 25 June 2015